| Latasha D Thornburg, | |
|
7777 E Us Highway 66, El Reno, OK 73036-9125 | |
| (405) 422-8800 | |
| Not Available |
| Full Name | Latasha D Thornburg |
|---|---|
| Gender | Female |
| Speciality | Counselor - Mental Health |
| Location | 7777 E Us Highway 66, El Reno, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033610001 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Latasha D Thornburg, 7777 E Us Highway 66, El Reno, OK 73036-9125 Ph: () - | Latasha D Thornburg, 7777 E Us Highway 66, El Reno, OK 73036-9125 Ph: (405) 422-8800 |
News Archive
A new study in the Journal of Nutrition Education and Behavior, published by Elsevier, explores real-time personal and employee safety experiences and perspectives of school nutrition professionals ranging from frontline staff to state leadership across the United States during the early weeks of the coronavirus pandemic.
Researchers at University of California San Diego School of Medicine report that elderly women who sit for more than 10 hours a day with low physical activity have cells that are biologically older by eight years compared to women who are less sedentary.
While testosterone replacement therapies may be controversial in males, new research in The FASEB Journal may extend this controversy to females too. That's because research involving mice, appearing in the April 2015 issue, suggests that there is an association between low levels of androgens (which includes testosterone), and atherosclerosis and obesity in females.
Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that, in addition to extensive generic erosion, the hypertension drug market will be constrained through 2018 by a pipeline containing very few emerging therapies with novel mechanisms of action. Gilead's darusentan was positioned to be the next emerging therapy with a novel mechanism of action to reach the hypertension market. However, following darusentan's failure to meet its primary endpoint in the recent DORADO-AC Phase III clinical trial, further development of the agent has been terminated.
Our immune system contains CD8+ T cells which protect us from various diseases such as cancer and viruses. Some of them are specifically tasked with killing cells infected with the HIV virus - and researchers from Karolinska Institutet in Sweden, together with international colleagues, have for the first time identified a key explanation for why these cells are unsuccessful in their task.
› Verified 4 days ago
Cara Everett, CMII Counselor Medicare: Not Enrolled in Medicare Practice Location: 7777 E Us Highway 66, El Reno, OK 73036 Phone: 405-424-7711 | |
Mrs. Kimberly Dawn Sells, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7777 E Us Highway 66, El Reno, OK 73036 Phone: 405-262-3209 | |
Julie Bakel, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7565 E Us Highway 66, El Reno, OK 73036 Phone: 405-295-6623 | |
Aja D'lin Woods, Counselor Medicare: Not Enrolled in Medicare Practice Location: 7777 E Rte 66, El Reno, OK 73036 Phone: 405-422-8800 | |
Ms. Ronda Lynn Moss, M.ED,, LADC Counselor Medicare: Not Enrolled in Medicare Practice Location: 7905 E Us Highway 66, El Reno, OK 73036 Phone: 405-262-0202 | |
Matt Alan Matthews, Counselor Medicare: Medicare Enrolled Practice Location: 7401-7799 Rte 66, El Reno, OK 73036 Phone: 405-422-8800 |